Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Language recovery after stroke
App | Video | PDF (278 pp) | Web


  Free Subscription


1 Cephalalgia
1 Eur J Pharmacol
4 Headache
2 Lancet
2 Lancet Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles


  1. CARPENET C, Guichard E, Tzourio C, Kurth T, et al
    Self-perceived attention deficit and hyperactivity symptom levels and risk of non-migraine and migraine headaches among university students: A cross-sectional study.
    Cephalalgia. 2018 Oct 22:333102418804155. doi: 10.1177/0333102418804155.
    PubMed     Text format     Abstract available

    Eur J Pharmacol

  2. GUO L, Zhao L, Ming P, Hong L, et al
    Sumatriptan inhibits the electrophysiological activity of ASICs in rat trigeminal ganglion neurons.
    Eur J Pharmacol. 2018 Oct 15. pii: S0014-2999(18)30587.
    PubMed     Text format     Abstract available


  3. ROSEN N, Pearlman E, Ruff D, Day K, et al
    100% Response Rate to Galcanezumab in Patients With Episodic Migraine: A Post Hoc Analysis of the Results From Phase 3, Randomized, Double-Blind, Placebo-Controlled EVOLVE-1 and EVOLVE-2 Studies.
    Headache. 2018;58:1347-1357.
    PubMed     Text format     Abstract available

  4. DODICK DW, Tepper SJ, Lipton RB, Buse DC, et al
    Improving Medical Communication in Migraine Management: A Modified Delphi Study to Develop a Digital Migraine Tracker.
    Headache. 2018;58:1358-1372.
    PubMed     Text format     Abstract available

  5. TOGHA M, Razeghi Jahromi S, Ghorbani Z, Martami F, et al
    Serum Vitamin D Status in a Group of Migraine Patients Compared With Healthy Controls: A Case-Control Study.
    Headache. 2018 Oct 20. doi: 10.1111/head.13423.
    PubMed     Text format     Abstract available

  6. LIPTON RB, Munjal S, Alam A, Buse DC, et al
    Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences.
    Headache. 2018;58:1408-1426.
    PubMed     Text format     Abstract available


    A new opportunity after migraine treatment failure?
    Lancet. 2018 Oct 22. pii: S0140-6736(18)32606.
    PubMed     Text format    

  8. REUTER U, Goadsby PJ, Lanteri-Minet M, Wen S, et al
    Efficacy and tolerability of erenumab in patients with episodic migraine in whom two-to-four previous preventive treatments were unsuccessful: a randomised, double-blind, placebo-controlled, phase 3b study.
    Lancet. 2018 Oct 22. pii: S0140-6736(18)32534.
    PubMed     Text format     Abstract available

    Lancet Neurol

    GBD 2016: still no improvement in the burden of migraine.
    Lancet Neurol. 2018;17:929-930.
    PubMed     Text format    

  10. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    Lancet Neurol. 2018;17:954-976.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.